https://www.thebodypro.com/author/glaxo-smith-kline

Latest by GlaxoSmithKline

Promo Image
News

GlaxoSmithKline Announces New Program to Provide Financial Assistance for Eligible HIV Patients in the U.S.

Research Triangle Park -- GlaxoSmithKline [NYSE: GSK] announced today the launch of a new Patient Savings Card designed to help eligible patients improve compliance with their HIV regimens by reducing their out-of-pocket expenses for GSK HIV medica...

Promo Image
News

Agenerase (Amprenavir) Oral Solution and 50-mg Capsules to Be Discontinued in the U.S.

Dear Healthcare Provider:

This letter is intended to inform you that GlaxoSmithKline will be discontinuing the sale of Agenerase Oral Solution and 50 mg Capsules in the US by the end of October 2007. This action is not the result of any safety or ef...

Promo Image

GSK Discontinues Clinical Development of Investigational Protease Inhibitor Brecanavir (640385)

GlaxoSmithKline plc (GSK) today confirms that, due to insurmountable issues regarding formulation, the clinical development program for the investigational HIV protease inhibitor brecanavir has been discontinued. Brecanavir had reached Phase II devel...

Promo Image

GlaxoSmithKline Begins Testing New Technology to Protect Patients Against Counterfeit Medicine

Research Triangle Park, NC -- GlaxoSmithKline has begun distributing a medicine tagged with radio frequency identification (RFID) technology as part of a pilot project to help protect patient safety.

The tags will be placed on all bottles of Trizivi...